Jack J. Tobin Sells 2,325 Shares of CME Group Inc (CME) Stock

CME Group Inc (NASDAQ:CME) insider Jack J. Tobin sold 2,325 shares of the company’s stock in a transaction dated Monday, December 18th. The shares were sold at an average price of $152.28, for a total transaction of $354,051.00. Following the completion of the transaction, the insider now owns 17,574 shares in the company, valued at $2,676,168.72. The transaction was disclosed in a filing with the SEC, which is available at this link.

Shares of CME Group Inc (CME) opened at $149.44 on Thursday. The stock has a market cap of $50,921.51, a P/E ratio of 31.41, a P/E/G ratio of 3.09 and a beta of 0.73. CME Group Inc has a 1 year low of $113.27 and a 1 year high of $155.29. The company has a current ratio of 1.05, a quick ratio of 1.05 and a debt-to-equity ratio of 0.11.

CME Group (NASDAQ:CME) last posted its earnings results on Thursday, October 26th. The financial services provider reported $1.19 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.16 by $0.03. The firm had revenue of $890.80 million during the quarter, compared to the consensus estimate of $890.22 million. CME Group had a net margin of 40.94% and a return on equity of 7.89%. The company’s revenue was up 5.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.05 EPS. analysts expect that CME Group Inc will post 4.77 earnings per share for the current year.

The firm also recently announced a dividend, which will be paid on Tuesday, January 16th. Investors of record on Thursday, December 28th will be given a dividend of $3.50 per share. The ex-dividend date of this dividend is Wednesday, December 27th. This is an increase from CME Group’s previous dividend of $3.25. CME Group’s dividend payout ratio is 59.86%.

Institutional investors and hedge funds have recently bought and sold shares of the stock. ST Germain D J Co. Inc. acquired a new stake in CME Group in the third quarter valued at approximately $232,000. Capital Advisors Inc. OK grew its position in CME Group by 10.7% in the second quarter. Capital Advisors Inc. OK now owns 84,533 shares of the financial services provider’s stock valued at $10,587,000 after acquiring an additional 8,198 shares in the last quarter. Marvin & Palmer Associates Inc. grew its position in CME Group by 100.7% in the second quarter. Marvin & Palmer Associates Inc. now owns 57,278 shares of the financial services provider’s stock valued at $7,173,000 after acquiring an additional 28,745 shares in the last quarter. Nippon Life Global Investors Americas Inc. grew its position in CME Group by 6.1% in the third quarter. Nippon Life Global Investors Americas Inc. now owns 87,970 shares of the financial services provider’s stock valued at $11,935,000 after acquiring an additional 5,080 shares in the last quarter. Finally, Captrust Financial Advisors acquired a new stake in CME Group in the second quarter valued at approximately $693,000. 82.70% of the stock is owned by hedge funds and other institutional investors.

CME has been the topic of several recent analyst reports. Citigroup increased their price objective on shares of CME Group from $138.00 to $155.00 and gave the stock a “buy” rating in a report on Thursday, October 19th. UBS reiterated a “buy” rating and set a $135.00 price objective (up from $134.00) on shares of CME Group in a report on Wednesday, September 6th. BidaskClub upgraded shares of CME Group from a “buy” rating to a “strong-buy” rating in a report on Wednesday, September 27th. Keefe, Bruyette & Woods reiterated a “hold” rating and set a $133.00 price objective on shares of CME Group in a report on Thursday, September 21st. Finally, Barclays increased their price objective on shares of CME Group from $139.00 to $149.00 and gave the stock an “overweight” rating in a report on Tuesday, October 10th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and seven have assigned a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus target price of $141.75.

WARNING: This article was posted by Community Financial News and is the sole property of of Community Financial News. If you are accessing this article on another site, it was illegally copied and reposted in violation of US and international copyright legislation. The correct version of this article can be read at https://www.com-unik.info/2017/12/21/jack-j-tobin-sells-2325-shares-of-cme-group-inc-cme-stock.html.

CME Group Company Profile

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Insider Buying and Selling by Quarter for CME Group (NASDAQ:CME)

What are top analysts saying about CME Group? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for CME Group and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit